ALKHATIB, MOHAMMAD OMAR AHMAD
ALKHATIB, MOHAMMAD OMAR AHMAD
Dipartimento di Medicina Sperimentale
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers
2020-01-01 Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; Yu La Rosa, K; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini Silberstein, F; Perno, C; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
2021-01-01 Piermatteo, L; Alkhatib, M; D’Anna, S; Malagnino, V; Bertoli, A; Andreassi, E; Basile, E; Iuvara, A; Maria De Cristofaro, ; Cappiello, G; Cerva, C; Minichini, C; Pisaturo, M; Starace, M; Coppola, N; Fontana, C; Grelli, S; Ceccherini-Silberstein, F; Andreoni, M; Gill, Us; Kennedy, Ptf; Sarmati, L; Salpini, R; Svicher, V
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
2025-01-01 Salpini, R; D'Anna, S; Alkhatib, M; Piermatteo, L; Tavelli, A; Benedetti, L; Quiros-Roldan, E; Cingolani, A; Papalini, C; Carrara, S; Malagnino, V; Puoti, M; Sarmati, L; Ceccherini-Silberstein, F; Perno, Cf; Monforte, Ad; Svicher, V
SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays
2022-08-02 Alkhatib, M; Carioti, L; D'Anna, S; Ceccherini-Silberstein, F; Svicher, V; Salpini, R
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach
2023-06-12 Ambrosio, Fa; Costa, G; Romeo, I; Esposito, F; Alkhatib, M; Salpini, R; Svicher, V; Corona, A; Malune, P; Tramontano, E; Ceccherini-Silberstein, F; Alcaro, S; Artese, A
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach
2022-11-03 Romeo, I; Ambrosio, Fa; Costa, G; Corona, A; Alkhatib, M; Salpini, R; Lemme, S; Vergni, D; Svicher, V; Santoro, M; Tramontano, E; Ceccherini-Silberstein, F; Artese, A; Alcaro, S
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2020 | Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers | Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; Yu La Rosa, K; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini Silberstein, F; Perno, C; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V | Articolo su rivista | |
| 1-gen-2021 | HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation | Piermatteo, L; Alkhatib, M; D’Anna, S; Malagnino, V; Bertoli, A; Andreassi, E; Basile, E; Iuvara, A; Maria De Cristofaro, ; Cappiello, G; Cerva, C; Minichini, C; Pisaturo, M; Starace, M; Coppola, N; Fontana, C; Grelli, S; Ceccherini-Silberstein, F; Andreoni, M; Gill, Us; Kennedy, Ptf; Sarmati, L; Salpini, R; Svicher, V | Articolo su rivista | |
| 1-gen-2025 | Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy | Salpini, R; D'Anna, S; Alkhatib, M; Piermatteo, L; Tavelli, A; Benedetti, L; Quiros-Roldan, E; Cingolani, A; Papalini, C; Carrara, S; Malagnino, V; Puoti, M; Sarmati, L; Ceccherini-Silberstein, F; Perno, Cf; Monforte, Ad; Svicher, V | Articolo su rivista | |
| 2-ago-2022 | SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays | Alkhatib, M; Carioti, L; D'Anna, S; Ceccherini-Silberstein, F; Svicher, V; Salpini, R | Articolo su rivista | |
| 12-giu-2023 | Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach | Ambrosio, Fa; Costa, G; Romeo, I; Esposito, F; Alkhatib, M; Salpini, R; Svicher, V; Corona, A; Malune, P; Tramontano, E; Ceccherini-Silberstein, F; Alcaro, S; Artese, A | Articolo su rivista | |
| 3-nov-2022 | Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach | Romeo, I; Ambrosio, Fa; Costa, G; Corona, A; Alkhatib, M; Salpini, R; Lemme, S; Vergni, D; Svicher, V; Santoro, M; Tramontano, E; Ceccherini-Silberstein, F; Artese, A; Alcaro, S | Articolo su rivista |